LGVN [NASD]
Longeveron Inc.
Index- P/E- EPS (ttm)-0.90 Insider Own20.62% Shs Outstand20.03M Perf Week19.69%
Market Cap158.40M Forward P/E- EPS next Y-0.94 Insider Trans-0.51% Shs Float4.64M Perf Month-17.58%
Income-17.00M PEG- EPS next Q-0.23 Inst Own8.60% Short Float6.79% Perf Quarter17.02%
Sales1.30M P/S121.85 EPS this Y-353.10% Inst Trans- Short Ratio0.06 Perf Half Y168.48%
Book/sh1.87 P/B4.49 EPS next Y- ROA-43.40% Target Price18.00 Perf Year36.87%
Cash/sh1.86 P/C4.51 EPS next 5Y- ROE-51.70% 52W Range2.84 - 45.00 Perf YTD-30.49%
Dividend- P/FCF- EPS past 5Y- ROI-45.70% 52W High-81.36% Beta-
Dividend %- Quick Ratio13.10 Sales past 5Y- Gross Margin45.20% 52W Low195.41% ATR1.18
Employees18 Current Ratio13.10 Sales Q/Q-83.30% Oper. Margin- RSI (14)46.53 Volatility12.30% 13.72%
OptionableNo Debt/Eq0.00 EPS Q/Q-180.20% Profit Margin- Rel Volume0.05 Prev Close9.12
ShortableYes LT Debt/Eq0.00 EarningsMay 13 BMO Payout- Avg Volume5.32M Price8.39
Recom- SMA20-11.78% SMA50-5.91% SMA2002.71% Volume246,118 Change-8.00%
May-13-22 08:00AM  
07:12AM  
May-09-22 04:15PM  
08:30AM  
Apr-28-22 01:53PM  
Apr-14-22 08:58AM  
Apr-13-22 08:00AM  
07:30AM  
Apr-08-22 05:02PM  
Apr-05-22 08:00AM  
Apr-01-22 06:30AM  
Mar-31-22 08:00AM  
07:48AM  
07:30AM  
Mar-24-22 08:00AM  
Mar-15-22 04:54PM  
08:00AM  
Mar-11-22 08:00AM  
06:10AM  
Mar-07-22 08:00AM  
Mar-02-22 08:00AM  
Feb-17-22 08:00AM  
Jan-27-22 05:38PM  
04:49PM  
Jan-26-22 09:10AM  
Jan-25-22 08:00AM  
Jan-17-22 07:32AM  
Jan-12-22 08:00AM  
Jan-05-22 12:16PM  
08:00AM  
Jan-04-22 08:00AM  
Dec-17-21 01:50PM  
Dec-10-21 01:32PM  
Dec-09-21 06:45AM  
Dec-07-21 01:51PM  
Dec-06-21 05:00PM  
08:00AM  
Dec-05-21 02:05PM  
05:31AM  
Dec-03-21 04:30PM  
11:17AM  
07:32AM  
Dec-01-21 03:17AM  
Nov-30-21 03:20PM  
12:43PM  
Nov-24-21 06:20PM  
12:25PM  
Nov-23-21 04:22PM  
Nov-22-21 04:59PM  
03:42PM  
Nov-19-21 06:19AM  
Nov-18-21 02:31PM  
12:33PM  
10:57AM  
10:37AM  
10:21AM  
08:00AM  
07:04AM  
Nov-14-21 11:55PM  
Nov-12-21 02:22PM  
11:00AM  
10:49AM  
08:00AM  
07:55AM  
Nov-11-21 06:50PM  
Nov-10-21 02:54PM  
01:15PM  
10:45AM  
10:00AM  
Nov-09-21 03:06PM  
02:48PM  
01:55PM  
01:15PM  
09:20AM  
Nov-08-21 01:03PM  
12:00PM  
11:00AM  
08:30AM  
07:40AM  
Nov-07-21 10:40PM  
08:39PM  
01:15PM  
Nov-05-21 06:05PM  
03:45PM  
02:30PM  
01:42PM  
12:25PM  
11:00AM  
08:30AM  
Nov-04-21 08:15AM  
Nov-03-21 10:55PM  
05:15PM  
01:34PM  
11:00AM  
09:58AM  
07:45AM  
01:10AM  
Nov-02-21 09:00PM  
10:29AM  
08:00AM  
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hare JoshuaChief Scientific OfficerApr 19Sale10.00787807,913,263Apr 20 05:00 PM
Hare JoshuaChief Scientific OfficerApr 18Sale10.0019,922199,2907,913,341Apr 20 05:00 PM
Green GeoffCEOOct 13Buy3.811,0003,810139,723Oct 14 09:00 AM
Soffer RockDirectorOct 13Buy3.7612,00045,12051,757Oct 13 06:00 PM
Hare JoshuaChief Scientific OfficerOct 12Buy3.692,5009,2257,933,263Oct 14 09:00 AM
Soffer RockDirectorOct 12Buy3.574,00014,28039,757Oct 13 06:00 PM
Soffer RockDirectorOct 11Buy3.453,90013,45535,757Oct 13 06:00 PM
Hare JoshuaChief Scientific OfficerOct 08Buy3.393,01510,2217,930,763Oct 12 09:30 AM
Hare JoshuaChief Scientific OfficerOct 07Buy3.381,9856,7097,927,748Oct 12 09:30 AM
Lehr Paul TGeneral Counsel, SecretaryOct 07Buy3.341,7505,845116,366Oct 12 09:30 AM
Clavijo JamesCFO and TreasurerOct 07Buy3.345,00016,70079,598Oct 12 09:30 AM